StockTipsArenaBeta

BUY Divi's Laboratories Limited — Somil Mehta, Sharekhan

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

bySomil Mehta, SharekhanHorizon: NA (inferred 1–3 months)18 Aug 2026via CNBC Awaaz.

Entry₹8,602.5Inferred
Target₹9,200
Total upside +6.95% (call closed)
Stop loss₹8,300-3.52% risk
Exit₹9,20028 Aug 2026, 12:08 pm
Target hit+6.95%0.00%upside left
Follow Somil Mehta for new calls(34% target hit, 76 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Short-term call on DIVISLABSee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Aug 2026
12 supporting7 neutral2 opposing
Supports the BUY call (12)

1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·26 Aug · yesterday

PNB Housing, Divi's Labs Touch 52-Week Highs on Aug 26

NewsGoogle News·26 Aug · 2d ago

(opens in new tab)

Divi’s, TVS Motors, Dixon See Bullish Signals: Analyst

NewsGoogle News·26 Aug · 2d ago

(opens in new tab)

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·25 Aug · 3d ago

(opens in new tab)

Divi's Laboratories recommends ₹30 dividend, outlines TDS compliance

NewsGoogle News·23 Aug · 4d ago

(opens in new tab)
Neutral / worth noting (7)

Nifty 24,500 पर फिसला, Divi's, MCX और Eternal पर रखें नज़र!

NewsGoogle News·12 Aug · 2w ago

(opens in new tab)

Divi’s Laboratories Posts Q1 FY27 Earnings Call Transcript for Investors

NewsGoogle News·6 Aug · 3w ago

(opens in new tab)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·1 Aug · 4w ago

(opens in new tab)

Q1 results today: Divi's Labs, Muthoot Finance, APL Apollo among over 30 companies set to announce Q1 earnings

NewsLivemint·1 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (2)

Indian Pharma Stocks Face Volatility After US Tariff Proposal

NewsGoogle News·14 Aug · 2w ago

(opens in new tab)

4 advisors have active long-term SELL calls on this stock

Advisor consensus · adjacent horizon·3 Aug · 4w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Somil Mehta, Sharekhan

Every call and its outcome